Elevated FAM3C promotes cell epithelial– mesenchymal transition and cell migration in gastric cancer
暂无分享,去创建一个
X. Zou | Shanshan Shen | S. Nie | G. Duan | Mengyue Shi
[1] Changjiang Qin,et al. Sauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] Yan Fan,et al. ILEI is an important intermediate participating in the formation of TGF‐β1–induced renal tubular EMT , 2018, Cell biochemistry and function.
[3] Bowen Li,et al. SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling , 2017, Oncotarget.
[4] Muh-Hwa Yang,et al. Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness , 2017, Molecular oncology.
[5] Q. Mei,et al. ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways , 2017, Oncotarget.
[6] Weigang Zhang,et al. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT , 2017, Oncotarget.
[7] Jun Wang,et al. A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells , 2017, Scientific Reports.
[8] Q. Cui,et al. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice , 2017, Diabetes.
[9] Q. Gao,et al. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin‐like EMT inducer (ILEI) , 2017, IUBMB life.
[10] Jing Yang,et al. Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.
[11] M. Tomic-Canic,et al. Epithelial-mesenchymal transition in tissue repair and fibrosis , 2016, Cell and Tissue Research.
[12] F. Roviello,et al. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. , 2016, Cancer letters.
[13] Jian-Hua Fu,et al. Prognostic significance of FAM3C in esophageal squamous cell carcinoma , 2015, Diagnostic Pathology.
[14] B. Tang,et al. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. , 2015, Cancer letters.
[15] F. Giostra,et al. Methods and Results , 2014 .
[16] Zhe Zhang,et al. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer , 2014, Oncotarget.
[17] P. Gao,et al. ILEI: a novel marker for epithelial–mesenchymal transition and poor prognosis in colorectal cancer , 2014, Histopathology.
[18] Karin Aumayr,et al. Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regulated secretion during breast cancer progression , 2014, Breast Cancer Research.
[19] E. Thompson,et al. Targeting EMT in cancer: opportunities for pharmacological intervention. , 2014, Trends in pharmacological sciences.
[20] S. Jiao,et al. ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549 , 2014, Tumor Biology.
[21] Yun-peng Liu,et al. Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells , 2013, PloS one.
[22] N. Boku. HER2-positive gastric cancer , 2013, Gastric Cancer.
[23] Samy Lamouille,et al. TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression , 2013, Current opinion in oncology.
[24] Li Yang,et al. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. , 2011, Gastroenterology.
[25] Yoon-Koo Kang,et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.
[26] M. Korpal,et al. The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.
[27] H. Beug,et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. , 2006, Cancer cell.
[28] M. Oshimura,et al. PI3K-Akt pathway: Its functions and alterations in human cancer , 2004, Apoptosis.
[29] Michael A. Briggs,et al. Cloning, expression, and initial characterization of a novel cytokine-like gene family. , 2002, Genomics.
[30] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.